Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.7345 |
Intermediate Similarity |
NPD2928 |
Phase 2 |
0.6995 |
Remote Similarity |
NPD2332 |
Discontinued |
0.6703 |
Remote Similarity |
NPD4184 |
Clinical (unspecified phase) |
0.67 |
Remote Similarity |
NPD8410 |
Clinical (unspecified phase) |
0.6686 |
Remote Similarity |
NPD3262 |
Approved |
0.6632 |
Remote Similarity |
NPD2127 |
Suspended |
0.6611 |
Remote Similarity |
NPD4239 |
Clinical (unspecified phase) |
0.661 |
Remote Similarity |
NPD5358 |
Clinical (unspecified phase) |
0.6601 |
Remote Similarity |
NPD3014 |
Clinical (unspecified phase) |
0.6601 |
Remote Similarity |
NPD3013 |
Phase 3 |
0.6566 |
Remote Similarity |
NPD9726 |
Discontinued |
0.6522 |
Remote Similarity |
NPD2619 |
Clinical (unspecified phase) |
0.6522 |
Remote Similarity |
NPD2620 |
Phase 2 |
0.6519 |
Remote Similarity |
NPD8026 |
Phase 1 |
0.6507 |
Remote Similarity |
NPD4555 |
Clinical (unspecified phase) |
0.648 |
Remote Similarity |
NPD4998 |
Phase 3 |
0.648 |
Remote Similarity |
NPD4999 |
Phase 3 |
0.6455 |
Remote Similarity |
NPD6595 |
Phase 3 |
0.6436 |
Remote Similarity |
NPD2144 |
Approved |
0.6422 |
Remote Similarity |
NPD4612 |
Discontinued |
0.6395 |
Remote Similarity |
NPD786 |
Approved |
0.6378 |
Remote Similarity |
NPD5069 |
Clinical (unspecified phase) |
0.6373 |
Remote Similarity |
NPD4533 |
Clinical (unspecified phase) |
0.6373 |
Remote Similarity |
NPD2872 |
Phase 2 |
0.6368 |
Remote Similarity |
NPD2599 |
Approved |
0.6368 |
Remote Similarity |
NPD2601 |
Approved |
0.6368 |
Remote Similarity |
NPD2600 |
Approved |
0.6355 |
Remote Similarity |
NPD4683 |
Phase 3 |
0.6353 |
Remote Similarity |
NPD2140 |
Approved |
0.6353 |
Remote Similarity |
NPD2141 |
Approved |
0.6353 |
Remote Similarity |
NPD2142 |
Approved |
0.635 |
Remote Similarity |
NPD3814 |
Phase 1 |
0.6345 |
Remote Similarity |
NPD1038 |
Approved |
0.6343 |
Remote Similarity |
NPD1352 |
Discontinued |
0.6341 |
Remote Similarity |
NPD2189 |
Approved |
0.6341 |
Remote Similarity |
NPD2187 |
Approved |
0.6337 |
Remote Similarity |
NPD5486 |
Discontinued |
0.6335 |
Remote Similarity |
NPD3038 |
Discontinued |
0.6316 |
Remote Similarity |
NPD198 |
Clinical (unspecified phase) |
0.6289 |
Remote Similarity |
NPD706 |
Phase 1 |
0.6286 |
Remote Similarity |
NPD1427 |
Clinical (unspecified phase) |
0.6279 |
Remote Similarity |
NPD9506 |
Approved |
0.6278 |
Remote Similarity |
NPD2012 |
Clinical (unspecified phase) |
0.6276 |
Remote Similarity |
NPD2544 |
Clinical (unspecified phase) |
0.6264 |
Remote Similarity |
NPD2581 |
Approved |
0.6264 |
Remote Similarity |
NPD2582 |
Approved |
0.6263 |
Remote Similarity |
NPD1304 |
Clinical (unspecified phase) |
0.625 |
Remote Similarity |
NPD4563 |
Phase 2 |
0.625 |
Remote Similarity |
NPD3178 |
Discontinued |
0.6244 |
Remote Similarity |
NPD5458 |
Discontinued |
0.6243 |
Remote Similarity |
NPD5065 |
Approved |
0.6237 |
Remote Similarity |
NPD5611 |
Phase 2 |
0.6236 |
Remote Similarity |
NPD4703 |
Approved |
0.6236 |
Remote Similarity |
NPD4702 |
Approved |
0.623 |
Remote Similarity |
NPD4079 |
Approved |
0.623 |
Remote Similarity |
NPD4076 |
Approved |
0.6229 |
Remote Similarity |
NPD1722 |
Approved |
0.6223 |
Remote Similarity |
NPD3347 |
Clinical (unspecified phase) |
0.622 |
Remote Similarity |
NPD8458 |
Clinical (unspecified phase) |
0.6219 |
Remote Similarity |
NPD1982 |
Phase 1 |
0.6218 |
Remote Similarity |
NPD2092 |
Phase 2 |
0.6218 |
Remote Similarity |
NPD2095 |
Phase 2 |
0.6218 |
Remote Similarity |
NPD2094 |
Phase 2 |
0.6211 |
Remote Similarity |
NPD749 |
Clinical (unspecified phase) |
0.6209 |
Remote Similarity |
NPD276 |
Clinical (unspecified phase) |
0.6201 |
Remote Similarity |
NPD3100 |
Discontinued |
0.62 |
Remote Similarity |
NPD2482 |
Clinical (unspecified phase) |
0.6196 |
Remote Similarity |
NPD687 |
Clinical (unspecified phase) |
0.6193 |
Remote Similarity |
NPD2007 |
Clinical (unspecified phase) |
0.6193 |
Remote Similarity |
NPD3717 |
Discontinued |
0.619 |
Remote Similarity |
NPD8488 |
Clinical (unspecified phase) |
0.6186 |
Remote Similarity |
NPD2091 |
Phase 2 |
0.6186 |
Remote Similarity |
NPD2096 |
Phase 2 |
0.6182 |
Remote Similarity |
NPD3960 |
Clinical (unspecified phase) |
0.6181 |
Remote Similarity |
NPD802 |
Phase 2 |
0.6178 |
Remote Similarity |
NPD3506 |
Approved |
0.6178 |
Remote Similarity |
NPD3505 |
Approved |
0.6167 |
Remote Similarity |
NPD2172 |
Phase 1 |
0.6166 |
Remote Similarity |
NPD4649 |
Clinical (unspecified phase) |
0.6165 |
Remote Similarity |
NPD4023 |
Clinical (unspecified phase) |
0.6162 |
Remote Similarity |
NPD459 |
Clinical (unspecified phase) |
0.6162 |
Remote Similarity |
NPD2480 |
Clinical (unspecified phase) |
0.6158 |
Remote Similarity |
NPD5584 |
Clinical (unspecified phase) |
0.6158 |
Remote Similarity |
NPD482 |
Approved |
0.6154 |
Remote Similarity |
NPD2125 |
Clinical (unspecified phase) |
0.6154 |
Remote Similarity |
NPD6545 |
Clinical (unspecified phase) |
0.615 |
Remote Similarity |
NPD4174 |
Clinical (unspecified phase) |
0.6146 |
Remote Similarity |
NPD2930 |
Clinical (unspecified phase) |
0.6138 |
Remote Similarity |
NPD6828 |
Phase 2 |
0.6138 |
Remote Similarity |
NPD1567 |
Clinical (unspecified phase) |
0.6138 |
Remote Similarity |
NPD6827 |
Clinical (unspecified phase) |
0.6135 |
Remote Similarity |
NPD1392 |
Approved |
0.6131 |
Remote Similarity |
NPD1598 |
Discontinued |
0.6131 |
Remote Similarity |
NPD4615 |
Phase 2 |
0.6129 |
Remote Similarity |
NPD6635 |
Approved |
0.6124 |
Remote Similarity |
NPD7809 |
Clinical (unspecified phase) |
0.6124 |
Remote Similarity |
NPD8321 |
Discontinued |
0.6119 |
Remote Similarity |
NPD6226 |
Phase 3 |
0.6117 |
Remote Similarity |
NPD1915 |
Phase 1 |
0.6111 |
Remote Similarity |
NPD4374 |
Clinical (unspecified phase) |
0.6108 |
Remote Similarity |
NPD3825 |
Phase 3 |
0.6106 |
Remote Similarity |
NPD2509 |
Approved |
0.6106 |
Remote Similarity |
NPD2510 |
Approved |
0.61 |
Remote Similarity |
NPD5575 |
Clinical (unspecified phase) |
0.61 |
Remote Similarity |
NPD3485 |
Clinical (unspecified phase) |
0.6096 |
Remote Similarity |
NPD1002 |
Clinical (unspecified phase) |
0.6094 |
Remote Similarity |
NPD6203 |
Clinical (unspecified phase) |
0.6091 |
Remote Similarity |
NPD8431 |
Approved |
0.6089 |
Remote Similarity |
NPD2952 |
Discontinued |
0.6087 |
Remote Similarity |
NPD4862 |
Clinical (unspecified phase) |
0.6087 |
Remote Similarity |
NPD269 |
Clinical (unspecified phase) |
0.6082 |
Remote Similarity |
NPD1895 |
Discontinued |
0.608 |
Remote Similarity |
NPD6272 |
Phase 1 |
0.608 |
Remote Similarity |
NPD1395 |
Clinical (unspecified phase) |
0.608 |
Remote Similarity |
NPD7709 |
Discontinued |
0.6077 |
Remote Similarity |
NPD2466 |
Phase 3 |
0.6077 |
Remote Similarity |
NPD4462 |
Approved |
0.6077 |
Remote Similarity |
NPD6529 |
Discontinued |
0.6077 |
Remote Similarity |
NPD2465 |
Approved |
0.6077 |
Remote Similarity |
NPD2462 |
Phase 3 |
0.6077 |
Remote Similarity |
NPD4463 |
Approved |
0.6073 |
Remote Similarity |
NPD4128 |
Approved |
0.6071 |
Remote Similarity |
NPD6241 |
Phase 1 |
0.6071 |
Remote Similarity |
NPD2814 |
Clinical (unspecified phase) |
0.6071 |
Remote Similarity |
NPD6610 |
Clinical (unspecified phase) |
0.6067 |
Remote Similarity |
NPD3813 |
Approved |
0.6062 |
Remote Similarity |
NPD6555 |
Clinical (unspecified phase) |
0.6061 |
Remote Similarity |
NPD268 |
Approved |
0.6061 |
Remote Similarity |
NPD8110 |
Clinical (unspecified phase) |
0.6061 |
Remote Similarity |
NPD270 |
Clinical (unspecified phase) |
0.6061 |
Remote Similarity |
NPD6363 |
Clinical (unspecified phase) |
0.6061 |
Remote Similarity |
NPD271 |
Approved |
0.6051 |
Remote Similarity |
NPD1332 |
Clinical (unspecified phase) |
0.6049 |
Remote Similarity |
NPD8629 |
Discontinued |
0.6048 |
Remote Similarity |
NPD4990 |
Clinical (unspecified phase) |
0.6041 |
Remote Similarity |
NPD2591 |
Phase 2 |
0.6041 |
Remote Similarity |
NPD2793 |
Discontinued |
0.6041 |
Remote Similarity |
NPD3378 |
Clinical (unspecified phase) |
0.6033 |
Remote Similarity |
NPD6026 |
Approved |
0.603 |
Remote Similarity |
NPD5145 |
Clinical (unspecified phase) |
0.6028 |
Remote Similarity |
NPD8271 |
Discontinued |
0.6023 |
Remote Similarity |
NPD3475 |
Approved |
0.6023 |
Remote Similarity |
NPD3476 |
Approved |
0.6022 |
Remote Similarity |
NPD1403 |
Approved |
0.6022 |
Remote Similarity |
NPD1404 |
Approved |
0.602 |
Remote Similarity |
NPD460 |
Discontinued |
0.6019 |
Remote Similarity |
NPD3915 |
Approved |
0.601 |
Remote Similarity |
NPD7958 |
Clinical (unspecified phase) |
0.601 |
Remote Similarity |
NPD7957 |
Phase 1 |
0.601 |
Remote Similarity |
NPD3002 |
Clinical (unspecified phase) |
0.601 |
Remote Similarity |
NPD4072 |
Approved |
0.601 |
Remote Similarity |
NPD4181 |
Approved |
0.601 |
Remote Similarity |
NPD5590 |
Clinical (unspecified phase) |
0.601 |
Remote Similarity |
NPD4071 |
Approved |
0.601 |
Remote Similarity |
NPD7948 |
Phase 1 |
0.6009 |
Remote Similarity |
NPD8112 |
Clinical (unspecified phase) |
0.6 |
Remote Similarity |
NPD1707 |
Approved |
0.6 |
Remote Similarity |
NPD1363 |
Phase 3 |
0.6 |
Remote Similarity |
NPD4148 |
Approved |
0.6 |
Remote Similarity |
NPD1708 |
Approved |
0.6 |
Remote Similarity |
NPD6626 |
Approved |
0.5991 |
Remote Similarity |
NPD3916 |
Clinical (unspecified phase) |
0.5991 |
Remote Similarity |
NPD3918 |
Approved |
0.5991 |
Remote Similarity |
NPD3976 |
Clinical (unspecified phase) |
0.5991 |
Remote Similarity |
NPD3917 |
Approved |
0.599 |
Remote Similarity |
NPD2121 |
Clinical (unspecified phase) |
0.5989 |
Remote Similarity |
NPD1030 |
Approved |
0.5989 |
Remote Similarity |
NPD1027 |
Approved |
0.5989 |
Remote Similarity |
NPD1029 |
Clinical (unspecified phase) |
0.5989 |
Remote Similarity |
NPD418 |
Approved |
0.5981 |
Remote Similarity |
NPD8493 |
Clinical (unspecified phase) |
0.5981 |
Remote Similarity |
NPD7834 |
Approved |
0.5981 |
Remote Similarity |
NPD3371 |
Approved |
0.598 |
Remote Similarity |
NPD2152 |
Clinical (unspecified phase) |
0.5979 |
Remote Similarity |
NPD2642 |
Approved |
0.5979 |
Remote Similarity |
NPD2639 |
Approved |
0.5979 |
Remote Similarity |
NPD1248 |
Discontinued |
0.5979 |
Remote Similarity |
NPD8386 |
Phase 2 |
0.5972 |
Remote Similarity |
NPD5072 |
Discontinued |
0.5969 |
Remote Similarity |
NPD5596 |
Phase 2 |
0.5969 |
Remote Similarity |
NPD5728 |
Clinical (unspecified phase) |
0.5968 |
Remote Similarity |
NPD5255 |
Approved |
0.5967 |
Remote Similarity |
NPD2110 |
Approved |
0.5966 |
Remote Similarity |
NPD2896 |
Discontinued |
0.5965 |
Remote Similarity |
NPD3914 |
Clinical (unspecified phase) |
0.5962 |
Remote Similarity |
NPD7277 |
Approved |
0.5962 |
Remote Similarity |
NPD7276 |
Approved |
0.596 |
Remote Similarity |
NPD4902 |
Discontinued |
0.5957 |
Remote Similarity |
NPD8129 |
Discovery |
0.5955 |
Remote Similarity |
NPD1383 |
Phase 3 |
0.5955 |
Remote Similarity |
NPD1382 |
Phase 2 |
0.5955 |
Remote Similarity |
NPD1592 |
Phase 3 |
0.5952 |
Remote Similarity |
NPD7947 |
Clinical (unspecified phase) |
0.595 |
Remote Similarity |
NPD5117 |
Phase 2 |
0.595 |
Remote Similarity |
NPD1043 |
Phase 3 |
0.5947 |
Remote Similarity |
NPD2185 |
Clinical (unspecified phase) |
0.5947 |
Remote Similarity |
NPD2641 |
Approved |
0.5947 |
Remote Similarity |
NPD2640 |
Approved |
0.5943 |
Remote Similarity |
NPD5066 |
Phase 2 |
0.5943
|
Remote Similarity |
NPD5067 |
Phase 2 |